Thelin European Union - Norwegian - EMA (European Medicines Agency)

thelin

pfizer ltd. - sitaxentan natrium - hypertensjon, pulmonal - antihypertensiva, - behandling av pasienter med pulmonal arteriell hypertensjon (pah) klassifisert som who-funksjonsklasse iii, for å forbedre treningskapasiteten. effekt har vist seg ved primær lunghypertensjon og i lungehypertensjon assosiert med bindevevssykdom.

Nityr European Union - Norwegian - EMA (European Medicines Agency)

nityr

cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - behandling av voksne og paediatric pasienter med bekreftet diagnosen arvelig tyrosinemia type 1 (ht-1) i kombinasjon med kosttilskudd begrensning av tyrosin og fenylalanin.

Idarubicin Accord 10 mg/10 ml Norway - Norwegian - Statens legemiddelverk

idarubicin accord 10 mg/10 ml

accord healthcare b.v. - idarubicinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/10 ml

Idarubicin Accord 5 mg/5 ml Norway - Norwegian - Statens legemiddelverk

idarubicin accord 5 mg/5 ml

accord healthcare b.v. - idarubicinhydroklorid - injeksjonsvæske, oppløsning - 5 mg/5 ml

Atorvastatin Accord 10 mg Norway - Norwegian - Statens legemiddelverk

atorvastatin accord 10 mg

accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg

Atorvastatin Accord 20 mg Norway - Norwegian - Statens legemiddelverk

atorvastatin accord 20 mg

accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg

Atorvastatin Accord 40 mg Norway - Norwegian - Statens legemiddelverk

atorvastatin accord 40 mg

accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg

Atorvastatin Accord 80 mg Norway - Norwegian - Statens legemiddelverk

atorvastatin accord 80 mg

accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg

Ezetimibe Accord 10 mg Norway - Norwegian - Statens legemiddelverk

ezetimibe accord 10 mg

accord healthcare b.v. - ezetimib - tablett - 10 mg

Abiraterone Accord European Union - Norwegian - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.